Schubert & Co’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-38
Closed -$2.38K 1084
2023
Q1
$2.38K Buy
38
+11
+41% +$687 ﹤0.01% 821
2022
Q4
$1.69K Buy
27
+2
+8% +$115 ﹤0.01% 952
2022
Q3
$1K Sell
25
-1
-4% -$55 ﹤0.01% 1203
2022
Q2
$2K Buy
26
+12
+86% +$662 ﹤0.01% 848
2022
Q1
$1K Buy
14
+2
+17% +$115 ﹤0.01% 848
2021
Q4
$1K Buy
+12
New +$712 ﹤0.01% 795

Other funds holding PBH

Schubert & Co's PBH Position: Q2 2023 in Review

Schubert & Co sold out of Prestige Consumer Healthcare (PBH) in Q2 2023, closing a stake of 38 shares — an estimated $2.38K sold.

Schubert & Co first reported a position in PBH in Q4 2021 and held it in 6 quarters. The position peaked at $2.38K in Q1 2023. 279 funds tracked by Wall St. Rank hold PBH as of Q2 2023.

  • Schubert & Co reported no remaining Prestige Consumer Healthcare position as of Q2 2023 after selling out during the quarter.
  • Schubert & Co sold 38 Prestige Consumer Healthcare shares in Q2 2023, an estimated $2.38K.
  • Schubert & Co first reported a position in Prestige Consumer Healthcare in Q4 2021 and held it in 6 quarters.
  • Schubert & Co's Prestige Consumer Healthcare position peaked at $2.38K in Q1 2023.
  • 279 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2023.

Based on Schubert & Co's 13F filing for Q2 2023, filed 4 Aug 2023.